Clinical • Next-generation sequencing
|
EGFR (Epidermal growth factor receptor) • HER-2 (Human epidermal growth factor receptor 2) • CLDN18 (Claudin 18)
|
EGFR mutation • HER-2 negative • EGFR amplification
|
Erbitux (cetuximab) • albumin-bound paclitaxel • Cyramza (ramucirumab) • irinotecan • TheraCIM (nimotuzumab)